Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 47Bone Tissue Engineering MaterialsExtracellular vesicles in diseaseMesenchymal stem cell research

The DOI matches its Crossref record; 66 of the 68 references it cites were found in a registry or an index; 15 of the 23 sources its claims cite were checked for support.

A tailored bioactive 3D porous poly(lactic-acid)-exosome scaffold with osteo-immunomodulatory and osteogenic differentiation properties

Open access
Zhang, Yi, Huo, Mengjie, Wang, Yi, Xiao, Lan, Wu, Jianmei, Ma, Yaping, Zhang, Dingmei, Lang, Xuemei, Wang, Xin·2022·Journal of Biological Engineering

Abstract

Polylactic acid (PLA) is a versatile and biodegradable scaffold widely used in biomedical fields to repair tissue defects. Exosomes derived from mesenchymal stem cells (MSCs) are nano-sized extracellular vesicles, which play an important role in tissue engineering in recent years. The primary focus of this study was to develop a bioactive 3D PLA scaffold using exosome-based strategy to improve its osteogenic and immunoregulatory potential. We firstly successfully isolated MSC-derived exosomes (MSC-Exo). Morphological analysis revealed that MSC-Exo exhibits a typical cup-shaped morphology with high expression of exosomal marker CD63. MSC-Exo internalization into recipient cells were also investigated using flow cytometry and confocal laser scanning microscopy. Porous 3D PLA scaffold coated MSC-Exo were used for immunoregulatory and osteogenic testing. Exosomes released from 3D PLA scaffold were validated in RAW264.7 and hBMSCs. The cell proliferation and live/dead assay indicated high biocompatibility for PLA-Exo scaffold. Additionally, PLA-Exo scaffold could reduce the pro-inflammatory marker expression and reactive oxygen species (ROS) production, indicating potential immunoregulatory potential. It is also confirmed that PLA-Exo scaffold could potentiate osteogenic differentiation in the osteogenesis assay. In conclusion, our results demonstrate this bioactive 3D-printed PLA scaffolds with MSC-Exo modification holds immunoregulatory potential and favor osteogenic differentiation, thus having potential applications in bone tissue regeneration.

Overview

CoChat Summary

## TL;DR

This study built a 3D-printed porous PLA scaffold coated with mesenchymal stem cell-derived exosomes (MSC-Exo) and found that it was biocompatible, reduced inflammatory macrophage responses, and promoted osteogenic differentiation of hBMSCs. The authors conclude that the scaffold has potential for bone tissue regeneration, but they note that in vivo validation is still needed.

## Key findings

  • The isolated MSC-derived exosomes showed a typical spherical/cup-shaped morphology by TEM and expressed the exosomal marker CD63 by western blot.
  • The PLA-Exo scaffold had about 55% porosity and supported exosome release/internalization into recipient RAW264.7 cells and hBMSCs, with fluorescence signal increasing at 24 h after incubation.
  • In macrophages, PLA-Exo showed no significant cytotoxicity in MTT/live-dead assays, while inflammatory markers IL-1β, iNOS, IL-6, and TNF-α were significantly decreased by qRT-PCR; ROS levels were also reduced.
  • In hBMSCs, PLA-Exo increased osteogenic markers and mineralization: ALP, Runx2, OCN, and IBSP were elevated, ALP staining/fluorescence increased after 14 days, and Alizarin Red S staining showed more calcium deposition. The cytokine array also found increased angiopoietin-1, endoglin, IGFBP-3, IL-8, MCP-1, and SDF-1α.

## Methods

  • Design: In vitro fabrication and testing of a 3D-printed porous PLA scaffold modified with MSC-derived exosomes; comparison of PLA-Exo with PLA scaffolds without exosomes.
  • Data/sample: Exosomes were isolated from conditioned medium of human bone marrow-derived MSCs; recipient assays used RAW264.7 macrophages and hBMSCs.
  • Main analysis: Exosome characterization by TEM and western blot (CD63); scaffold and cell interactions by confocal microscopy/flow cytometry; viability by MTT and live/dead staining; inflammation/ROS by qRT-PCR, ROS assays, and cytometry; osteogenesis by ALP staining, ALP immunofluorescence, Alizarin Red S staining, qRT-PCR, and a cytokine array. Statistics used one-way ANOVA with Bonferroni tests.

## Limitations

  • The paper explicitly states that more studies, including in vivo study, are necessary to further validate the scaffold’s bio-functionality.
  • Evident from the text: the study is entirely in vitro, so translation to actual bone repair in living systems is not demonstrated in this paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13036-022-00301-z

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Characterization of hBMSCs-derived exosomes. A Morphological characterization of MSCs-derived exosomes with uranyl acetate negative staining. Isolated exosomes exhibited a cup-shaped morphology. B Western blot analysis of exosomal surface marker. Exosomes were found to be enriched for the exosomal surface marker CD63. C Flow cytometry analysis of exosome internalization into RAW264.7 cells. D The mean fluorescence intensity (MFI) obtained from RAW264.7 cells treated with or without MSC-Exo. E Internalization of MSC-Exo into hBSMCs. Cellular internalization of MSC-Exo by flow cytometric analysis. F MFI quantification of hBMSCs after 24 h of incubation with isolated exosomes. G Uptake of exosomes released from MSC-Exo by hBMSCs. Exosomes were prelabeled with PKH26. The internalization of the exosomes was evaluated by a confocal laser scanning microscopy
Fig. 1 Characterization of hBMSCs-derived exosomes. A Morphological characterization of MSCs-derived exosomes with uranyl acetate negative staining. Isolated exosomes exhibited a cup-shaped morphology. B Western blot analysis of exosomal surface marker. Exosomes were found to be enriched for the exosomal surface marker CD63. C Flow cytometry analysis of exosome internalization into RAW264.7 cells. D The mean fluorescence intensity (MFI) obtained from RAW264.7 cells treated with or without MSC-Exo. E Internalization of MSC-Exo into hBSMCs. Cellular internalization of MSC-Exo by flow cytometric analysis. F MFI quantification of hBMSCs after 24 h of incubation with isolated exosomes. G Uptake of exosomes released from MSC-Exo by hBMSCs. Exosomes were prelabeled with PKH26. The internalization of the exosomes was evaluated by a confocal laser scanning microscopyCC BY · PubMed Central
Fig. 2 Fabrication of PLA-Exo scaffold. A The view of the 3D printed PLA scaffold. B Representative imaging of PLA scaffold modified with PKH26-labeled exosomes. C Fluorescent imaging of exosomes released from PLA-Exo scaffold into Raw 264.7 cells. Cells were stained with phalloidin (green), nucleus (blue), and examined by a confocal laser scanning microscopy. D Uptake of exosomes released from PLA-Exo scaffold by hBMSCs. Exosomes were prelabeled with PKH26. The internalization of the exosomes released from scaffold was evaluated by a confocal laser scanning microscopy
Fig. 2 Fabrication of PLA-Exo scaffold. A The view of the 3D printed PLA scaffold. B Representative imaging of PLA scaffold modified with PKH26-labeled exosomes. C Fluorescent imaging of exosomes released from PLA-Exo scaffold into Raw 264.7 cells. Cells were stained with phalloidin (green), nucleus (blue), and examined by a confocal laser scanning microscopy. D Uptake of exosomes released from PLA-Exo scaffold by hBMSCs. Exosomes were prelabeled with PKH26. The internalization of the exosomes released from scaffold was evaluated by a confocal laser scanning microscopyCC BY · PubMed Central
Fig. 3 Effect of different scaffolds on Raw264.7 cells proliferation. A-C Cell proliferation via MTT assay in macrophages. Cell proliferation was evaluated by MTT assay at 1 day and 3 days. B-D Live and dead cells were assessed by a confocal laser scanning microscopy after labeling macrophages with fluorescein diacetate (FDA, green) and propidium iodide (PI, red). Green indicated living cells and dead cells were labeled as red fluorescence. Group a = control, group b = PLA scaffold, group c = PLA-Exo scaffold
Fig. 3 Effect of different scaffolds on Raw264.7 cells proliferation. A-C Cell proliferation via MTT assay in macrophages. Cell proliferation was evaluated by MTT assay at 1 day and 3 days. B-D Live and dead cells were assessed by a confocal laser scanning microscopy after labeling macrophages with fluorescein diacetate (FDA, green) and propidium iodide (PI, red). Green indicated living cells and dead cells were labeled as red fluorescence. Group a = control, group b = PLA scaffold, group c = PLA-Exo scaffoldCC BY · PubMed Central
Fig. 4 Effect of different scaffolds on the inflammatory macrophage polarization. A Confocal microscopy imaging of exosomes released from PLA-Exo scaffold internalization into pro-inflammatory macrophages. Cells were stained with DAPI (blue) and examined by a confocal laser scanning microscopy. B Representative confocal microscopy images of pro-inflammatory macrophages response to different scaffolds. Cells were fixed, stained for phalloidin (red), nuclei (blue) and visualized by a confocal laser scanning microscopy. C Representative CLSM images showing the changes of intracellular ROS levels. Nuclei were stained with Hoechst 33342 (blue). D ROS intensity detection using flow cytometry. Intracellular ROS levels decrease following PLA-Exo scaffold treatment: **** p < 0.0001. E qRT-PCR results of relative gene expression of pro-inflammatory cytokine. The values were normalized to GAPDH as a housekeeping gene. Significant difference (*p < 0.05, ****p < 0.0001). Group a = control, group b = PLA scaffold, group c = PLA-Exo scaffold
Fig. 4 Effect of different scaffolds on the inflammatory macrophage polarization. A Confocal microscopy imaging of exosomes released from PLA-Exo scaffold internalization into pro-inflammatory macrophages. Cells were stained with DAPI (blue) and examined by a confocal laser scanning microscopy. B Representative confocal microscopy images of pro-inflammatory macrophages response to different scaffolds. Cells were fixed, stained for phalloidin (red), nuclei (blue) and visualized by a confocal laser scanning microscopy. C Representative CLSM images showing the changes of intracellular ROS levels. Nuclei were stained with Hoechst 33342 (blue). D ROS intensity detection using flow cytometry. Intracellular ROS levels decrease following PLA-Exo scaffold treatment: **** p < 0.0001. E qRT-PCR results of relative gene expression of pro-inflammatory cytokine. The values were normalized to GAPDH as a housekeeping gene. Significant difference (*p < 0.05, ****p < 0.0001). Group a = control, group b = PLA scaffold, group c = PLA-Exo scaffoldCC BY · PubMed Central
Fig. 5 Cell proliferation analysis in hBMSCs. A-C Cell proliferation analysis. Cell viability was evaluated by MTT assay at 3 days and 5 days. B-D Live and dead assay of hBMSCs co-cultured with different scaffolds for 3 day and 5 days. The cells were stained with fluorescein diacetate (FDA, green) and propidium iodide (PI, red) and were examined by a confocal microscopy. Green indicated living cells and dead cells were labeled as red fluorescence. Group a = control, group b = PLA scaffold, group c = PLA-Exo scaffold
Fig. 5 Cell proliferation analysis in hBMSCs. A-C Cell proliferation analysis. Cell viability was evaluated by MTT assay at 3 days and 5 days. B-D Live and dead assay of hBMSCs co-cultured with different scaffolds for 3 day and 5 days. The cells were stained with fluorescein diacetate (FDA, green) and propidium iodide (PI, red) and were examined by a confocal microscopy. Green indicated living cells and dead cells were labeled as red fluorescence. Group a = control, group b = PLA scaffold, group c = PLA-Exo scaffoldCC BY · PubMed Central
Fig. 6 Osteogenic differentiation capacity of hBMSCs stimulated. A ALP staining images of hBMSCs cultured with different scaffolds at days 14. PLA-Exo scaffold improves the expression of ALP. B Immunofluorescence staining for osteogenic differentiation marker (ALP) in hBMSCs cultured with different scaffolds for 14 days. Cells were fixed, stained for ALP (green), phalloidin (red), and nuclei (blue), and examined by a confocal laser scanning microscopy. C Gene expression of osteogenesis-specific markers by qRT-PCR. Significant difference **p < 0.01, ***p < 0.001. D Representative images for cytokine array assay. hBMSCs were cultured with PLA or PLA-Exo scaffold for 3 days, and the cell culture supernatant were collected for human proteome XL cytokine array. E Quantification of cytokine array assay. Significant difference: *p < 0.05, **p < 0.01, ***p < 0.001). F Alizarin red S staining for calcium nodules formation at 21 days. G Calcium nodules formation was eluted and measured using a microplate reader at 405 nm. Significant difference: ****p < 0.0001. Group a = control, group b = PLA scaffold, group c = PLA-Exo scaffold
Fig. 6 Osteogenic differentiation capacity of hBMSCs stimulated. A ALP staining images of hBMSCs cultured with different scaffolds at days 14. PLA-Exo scaffold improves the expression of ALP. B Immunofluorescence staining for osteogenic differentiation marker (ALP) in hBMSCs cultured with different scaffolds for 14 days. Cells were fixed, stained for ALP (green), phalloidin (red), and nuclei (blue), and examined by a confocal laser scanning microscopy. C Gene expression of osteogenesis-specific markers by qRT-PCR. Significant difference **p < 0.01, ***p < 0.001. D Representative images for cytokine array assay. hBMSCs were cultured with PLA or PLA-Exo scaffold for 3 days, and the cell culture supernatant were collected for human proteome XL cytokine array. E Quantification of cytokine array assay. Significant difference: *p < 0.05, **p < 0.01, ***p < 0.001). F Alizarin red S staining for calcium nodules formation at 21 days. G Calcium nodules formation was eluted and measured using a microplate reader at 405 nm. Significant difference: ****p < 0.0001. Group a = control, group b = PLA scaffold, group c = PLA-Exo scaffoldCC BY · PubMed Central

Verification

Claims the paper makes

13 Valid · 0 Not valid · 5 Not checked · 31 Own results and interpretations

21 more claims

Create a free account to see all 49 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 19
  • It may state two separate claims as one. 10
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 68 references

Cited by

See all 47

Metadata

Authors
Zhang, Y., Huo, M., Wang, Y., Xiao, L., Wu, J., Ma, Y., Zhang, D., Lang, X., & Wang, X.
Affiliations
  • Zunyi Medical University (CN)
  • Queensland University of Technology (AU)
  • Chongqing University (CN)
Corresponding author
  • Lang, Xuemei
  • Wang, Xin
Venue
Journal of Biological Engineering
Published
2022-08-22
Volume
16
Issue
1
Pages
22-22
ISSN
1754-1611 (ISSN-L)
OpenAlex
W4292595916
Cited by
47
References
68
Citations by year
2026: 9 · 2025: 19 · 2024: 11 · 2023: 8
FWCI
2.48
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Engineering (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Griffith Research Online (submittedVersion, cc-by)
Funders
National Natural Science Foundation of China (31960209, F-934, 201701)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
polylactic acid scaffolds, mesenchymal stem cell-derived exosomes, 3D bioprinting, porous scaffolds, osteogenic differentiation, immune regulation, bone regeneration, exosome internalization, CD63, reactive oxygen species, pro-inflammatory markers, biocompatibility, bone marrow mesenchymal stem cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A tailored bioactive 3D porous poly(lactic-acid)-exosome scaffold with osteo-immunomodulatory and osteogenic differentiation properties. https://app.cochat.ai/papers/10.1186/s13036-022-00301-z
The paper
Zhang, Y., Huo, M., Wang, Y., Xiao, L., Wu, J., Ma, Y., Zhang, D., Lang, X., & Wang, X. (2022). A tailored bioactive 3D porous poly(lactic-acid)-exosome scaffold with osteo-immunomodulatory and osteogenic differentiation properties. Journal of Biological Engineering. https://doi.org/10.1186/s13036-022-00301-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.